Informations générales (source: ClinicalTrials.gov)
Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy (SocrAlt)
Interventional
N/A
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
mars 2025
janvier 2029
24 mai 2025
Social cognition, which refers to the ability to interpret social information and behave
accordingly in a social environment, is crucial in everyday life. But this ability has
been shown to be altered in patients with epilepsy, especially in medial temporal lobe
epilepsy, which leads to a deterioration in the patient's quality of life. However, the
mechanisms of those deficiencies remain largely unknown. The Team objective is to achieve
a structural and functional cartography of the social cognition network in 20 healthy
subjects and 20 patients with drug-resistant medial temporal lobe epilepsy (before and
one year after resective surgery of the epileptogenic focus). Social cognition
deficiencies will be assessed using a specifically dedicated neuropsychological
assessment validated in French (Batteries de Cognition Sociale BCS). Brain structural
analyses will be performed on a 3-Tesla MRI (3T MRI), including an anatomical T1
sequence, a High Angular Resolution Diffusion Imaging (HARDI) to assess the morphology
and macrostructural characteristics of long and short white matter tracts involved in
social cognition, and quantitative MRI and Hybrid Diffusion Imaging (HYDI) to assess
their microstructure. Functional connectivity will be assessed using an ultra-high-field
7-Tesla MRI (7T MRI), with acquisition in resting state and during specific social
cognition tasks. Joint analysis of structural and functional connectivity will enable the
team to assess the alterations of social cognition networks in patients with epilepsy and
their reorganisations after epilepsy surgery.
Etablissements
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
GHU PARIS PSY ET NEUROSCIENCES | Sophie DUPONT, MD | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
NeuroSpin - CEA - 91191 - Gif-sur-Yvette - France | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion criteria:
- Age ≥ 18 years old
- Good understanding of written and verbal French language
- Written consent signed by the subject
- Patients with focal temporal lobe epilepsy for at least one year, drug-resistant,
due to a hippocampal sclerosis
- Undergoing presurgical assessment
- Affiliated to a social security system
- Age ≥ 18 years old
- Good understanding of written and verbal French language
- Written consent signed by the subject
- Patients with focal temporal lobe epilepsy for at least one year, drug-resistant,
due to a hippocampal sclerosis
- Undergoing presurgical assessment
- Affiliated to a social security system
- Under juridical protection
- With claustrophobia or any MRI contra-indication
- Pregnancy or lactation
- Participation in another research with an exclusion period
- Refusal to be notified in the event of anomalies discovered during the performance
of an MRI sequence